HighTower Advisors
ANGO icon

HighTower Advisors’s AngioDynamics ANGO Stock Holding History

HighTower Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-19,871
Closed -$516K – 3294
2021
Q3 		$516K Buy
19,871
+519
+3% +$13.9K ﹤0.01% 2037
2021
Q2 		$527K Buy
+19,352
New +$473K ﹤0.01% 2017

Other funds holding ANGO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

HighTower Advisors's ANGO Position: Q4 2021 in Review

HighTower Advisors sold out of AngioDynamics (ANGO) in Q4 2021, closing a stake of 19,871 shares — an estimated $516K sold.

HighTower Advisors first reported a position in ANGO in Q2 2021 and held it in 2 quarters. The position peaked at $527K in Q2 2021. 170 funds tracked by Wall St. Rank hold ANGO as of Q4 2021.

  • HighTower Advisors reported no remaining AngioDynamics position as of Q4 2021 after selling out during the quarter.
  • HighTower Advisors sold 19,871 AngioDynamics shares in Q4 2021, an estimated $516K.
  • HighTower Advisors first reported a position in AngioDynamics in Q2 2021 and held it in 2 quarters.
  • HighTower Advisors's AngioDynamics position peaked at $527K in Q2 2021.
  • 170 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2021.

Based on HighTower Advisors's 13F filing for Q4 2021, filed 10 Feb 2022.